tiprankstipranks
Advertisement
Advertisement

IPSC Stock Latest News

Century Therapeutics reports Q1 EPS (11c), consensus (17c)
The FlyCentury Therapeutics reports Q1 EPS (11c), consensus (17c)
7d ago
IPSC
Century Therapeutics price target raised to $5 from $2 at H.C. Wainwright
PremiumThe Fly
Century Therapeutics price target raised to $5 from $2 at H.C. Wainwright
29d ago
IPSC
Century Therapeutics Updates ATM Program to Enhance Liquidity
PremiumCompany Announcements
Century Therapeutics Updates ATM Program to Enhance Liquidity
2M ago
8K
IPSC
Century Therapeutics Reports 2025 Results and Pipeline Progress
PremiumCompany Announcements
Century Therapeutics Reports 2025 Results and Pipeline Progress
2M ago
8K
IPSC
Century Therapeutics reports FY25 EPS (14c), consensus (17c)
PremiumThe Fly
Century Therapeutics reports FY25 EPS (14c), consensus (17c)
2M ago
IPSC
IPSC Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsIPSC Upcoming Earnings Report: What to Expect?
2M ago
IPSC
Century Therapeutics initiated with a Buy at TD Cowen
Premium
The Fly
Century Therapeutics initiated with a Buy at TD Cowen
3M ago
IPSC
Century Therapeutics files to sell 176.09M shares of common stock for holders
Premium
The Fly
Century Therapeutics files to sell 176.09M shares of common stock for holders
3M ago
IPSC
Century Therapeutics Regains Nasdaq Compliance, Halts Reverse Split
PremiumCompany Announcements
Century Therapeutics Regains Nasdaq Compliance, Halts Reverse Split
4M ago
8K
IPSC
Century Therapeutics price target raised to $4 from $2 at Piper Sandler
PremiumThe Fly
Century Therapeutics price target raised to $4 from $2 at Piper Sandler
4M ago
IPSC
Century Therapeutics Highlights Progress in Immune-Evasive Cell Therapies
PremiumCompany Announcements
Century Therapeutics Highlights Progress in Immune-Evasive Cell Therapies
4M ago
8K
IPSC
Century Therapeutics price target lowered to $6.60 from $8 at Clear Street
PremiumThe Fly
Century Therapeutics price target lowered to $6.60 from $8 at Clear Street
4M ago
IPSC
Century Therapeutics Announces Oversubscribed $135 Million Financing
PremiumCompany AnnouncementsCentury Therapeutics Announces Oversubscribed $135 Million Financing
4M ago
8K
IPSC
Century Therapeutics prices 117.4M shares at $1.15 in private placement
Premium
The Fly
Century Therapeutics prices 117.4M shares at $1.15 in private placement
4M ago
IPSC
Century Therapeutics announces resignation of board member
Premium
Company Announcements
Century Therapeutics announces resignation of board member
5M ago
8K
IPSC
Century Therapeutics Updates on Cell Therapy Advancements
PremiumCompany Announcements
Century Therapeutics Updates on Cell Therapy Advancements
5M ago
8K
IPSC
Century Therapeutics Expands Board with New Appointments
PremiumCompany Announcements
Century Therapeutics Expands Board with New Appointments
5M ago
8K
IPSC
Century Therapeutics appoints Lee, Murphy to board of directors
PremiumThe Fly
Century Therapeutics appoints Lee, Murphy to board of directors
5M ago
IPSC
Century Therapeutics downgraded to Market Perform from Outperform at Leerink
PremiumThe Fly
Century Therapeutics downgraded to Market Perform from Outperform at Leerink
6M ago
IPSC
Century Therapeutics Reports Positive Q3 2025 Earnings
PremiumCompany AnnouncementsCentury Therapeutics Reports Positive Q3 2025 Earnings
6M ago
IPSC
Century Therapeutics Launches Type 1 Diabetes Program
Premium
Company Announcements
Century Therapeutics Launches Type 1 Diabetes Program
6M ago
8K
IPSC
Century Therapeutics reports Q3 EPS (40c) vs (37c) last year
Premium
The Fly
Century Therapeutics reports Q3 EPS (40c) vs (37c) last year
6M ago
IPSC

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >